Selective blockade of apoptosis by in vivo electroporation-mediated gene transfer combined with portal infusion of plasmid DNA attenuates liver cirrhosis

Minerva Chirurgica

Volumn 67, Issue 3, 2012, Pages 249-255

  Miyahara, T ^a   Umeda, Y ^a   Yoshikawa, S ^a   Matsuno, Y ^a   Iwata, H ^a   Takemura, H ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Electroporation; Rats, transgenic

Indexed keywords

DNA;

ANIMAL; APOPTOSIS; ARTICLE; ELECTROPORATION; GENE TRANSFER; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; PLASMID; PORTAL VEIN; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; DNA; ELECTROPORATION; GENE TRANSFER TECHNIQUES; INFUSIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; PLASMIDS; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867155076     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SL. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993;4:403-9. (Pubitemid 24308308)
2. Hickman M.A., Malone R.W., Lehmann-Bruinsma K., Sih T.R., Knoell D., Szoka F.C. et al. Gene expression following direct injection of DNA into liver. Hum Gene Ther 1994;5:1477-83.
3. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989;243:375-8. (Pubitemid 19047511)
4. Matsuno Y, Iwata H, Umeda Y, Takagi H, Mori Y, Kosugi A et al. Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis. Gene Ther 2003;10:1559-66. (Pubitemid 37063261)
5. Matsuki Y, Li L, Hsu HC, Yang PA, Zheng R, Edwards CK 3rd etal. Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells. Cell Death Differ 2002,9:626-35. (Pubitemid 34618868)
6. Liu F, Huang L. Electric gene transfer to the liver following systemic administration of plasmid DNA. Gene Ther 2002;9:1116-9.
7. Budker V, Zhang G, Knechtle S, Wolff JA. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther 1996;3:593-8. (Pubitemid 26258274)
8. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-8.
9. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-3. (Pubitemid 19277521)
10. Umeda Y, Hirose H, Yoshikawa S, Matsuno Y, Fukumoto Y, Nina T et al. Non-viral gene gun-mediated CTLA4-Ig gene transfer for modification of donor organs. Transplant Proc 2001;33:243-5. (Pubitemid 32237356)
11. Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim I, Takahama Y et al. Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J MoI Med 2006;17:503-9.
12. Oe H, Kaido T, Mori A, Onodera H, Imamura M. Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats. Hepatogastroenterology 2005;52:1393-7. (Pubitemid 41391000)
13. Xue F, Takahara T, Yata Y, Kuwabara Y, Shinno E, Nonome K et al. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 2003;52:694-700. (Pubitemid 36528872)
14. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-30. (Pubitemid 29068532)
15. Yuge K, Takahashi T, Nagano S, Terazaki Y, Murofushi Y, Ushikoshi H et al. Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma. Int J Oncol 2005;27:77-85.
16. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-5.
17. Wang H, Reaves PY, Gardon ML, Keene K, Goldberg DS, Gelband CH et al. Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR. Hypertension 2000;35:202-8. (Pubitemid 30054173)
18. Umeda Y, Marui T, Matsuno Y, Shirahashi K, Iwata H, Takagi H et al. Skeletal muscle targeting in vivo electroporation mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice. Lab Invest 2004;84:836-44. (Pubitemid 38833243)
19. Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005; 10927-39.
20. Szuster-Ciesielska A, Daniluk J, Bojarska-Junak A. Apoptosis of blood mononuclear cells in alcoholic liver cirrhosis. The influence of in vitro ethanol treatment and zinc supplementation. Toxicology 2005;212:12434.
21. Yoneyama K, Goto T, Miura K, Mikami K, Ohshima S, Nakane K et al. The expression of Fas and Fas ligand, and the effects of interferon in chronic liver diseases with hepatitis C virus. Hepatol Res 2002;24:327-37. (Pubitemid 36004141)
22. Pianko S, Patella S, Ostapowicz G, Desmond P, Sievert W. Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J Viral Hepat 2001;8:406-13.
23. Fox CK, Furtwaengler A, Nepomuceno RR, Martinez OM, Krams SM. Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver 2001;21:272-9. (Pubitemid 32677384)
24. Ballardini G, Guidi M, Susca M, Ghetti S, Grassi A, Lari F et al. Bile duct cell apoptosis is a rare event in primary biliary cirrhosis. Dig Liver Dis 2001;33:151-6. (Pubitemid 32294178)